Cite
HARVARD Citation
Zhou, N. et al. (n.d.). Characterization of NS5A polymorphisms and their impact on response rates in patients with HCV genotype 2 treated with daclatasvir-based regimens. Journal of antimicrobial chemotherapy. pp. 3495-3505. [Online].